Neuro-interventional Devices Market, by Product Type (Embolization Coils, Carotid Stents, Intracranial Stents, Neurovascular Thrombectomy, Flow Disruption, Flow Diverters, Intrasaccular Devices, Liquid Embolic Coils, Balloons, and Stent Retrievers), by Te

Neuro-interventional Devices Market, by Product Type (Embolization Coils, Carotid Stents, Intracranial Stents, Neurovascular Thrombectomy, Flow Disruption, Flow Diverters, Intrasaccular Devices, Liquid Embolic Coils, Balloons, and Stent Retrievers), by Technique (Neurothrombectomy Procedure, Cerebral Angiography, Stenting, Coiling Procedures, and Flow Disruption), by End User (Hospitals, Clinics, and Ambulatory Surgical Centers), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028

Interventional neuroradiology (INR), also known as neuro-interventional surgery (NIS), is a medical subspecialty of neurosurgery, neurology, and radiology, which focuses on minimally invasive image-based technologies and processes. It is used for diagnosis and treatment of diseases related to spine, head, and neck. The products included in neurointerventional devices consist of clips, stents, and coils. These are utilized for treating of various neurovascular disorders such as cerebral artery stenosis, brain aneurysms, brain arteriovenous malformation (AVM), carotid-cavernous fistula (CCF), dural arteriovenous fistula (dAVFs), and extracranial (brachiocephalic) atherosclerosis. Minimally invasive procedures are used for variety of treatments such as stroke treatment by delivering clot-busting drugs directly to the site of the blockage, spinal treatments by injecting bone cement into a fractured vertebra in order to reinforce the bone, and aneurysm therapy by inserting platinum coils into the aneurysm bulge to prevent clotting and rupture.
Market Dynamics
Market players are focusing on new product launches, which is expected to propel the global neuro-interventional devices market growth during the forecast period. For instance, in December 2019, Imperative Care, Inc., a biotechnology company completed the initial closing of a Series C financing of US$ 85 million to support the commercial launch of the company’s portfolio that includes the latest advancement in neurovascular devices used for the treatment of ischemic and hemorrhagic strokes. The company received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for access catheters which helps in smooth and consistent navigation into blood vessels of the brain. The company also received U.S. FDA clearance for its ZOOM Aspiration System, designed to simplify clot removal during ischemic stroke.
Key features of the study:
This report provides an in-depth analysis of the global neuro-interventional devices market, and provides market size (US$ Mn) and compound annual growth rate (CAGR%) for the forecast period (2022-2028), considering 2021 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global neuro-interventional devices market based on the following parameters – company highlights, products portfolio, key highlights, financial performance, strategies
Key companies covered as a part of this study include Penumbra, Inc., Stryker Corporation, Medtronic PLC., Johnson & Johnson Services, Inc., Terumo Corporation, Insera Therapeutics Inc., Anaconda Biomed S.L., and Perflow Medical Ltd.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The global neuro-interventional devices market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have an ease in decision-making through various strategy matrices used in analyzing the global neuro-interventional devices market
Detailed Segmentation:
Global Neuro-interventional Devices Market, By Product Type
Embolization Coils
Carotid Stents
Intracranial Stents
Neurovascular Thrombectomy
Flow Disruption
Flow Diverters
Intrasaccular Devices
Liquid Embolic Coils
Balloons
Stent Retrievers
Global Neuro-interventional Devices Market, By Technique
Neurothrombectomy Procedure
Cerebral Angiography
Stenting
Coiling Procedures
Flow Disruption
Global Neuro-interventional Devices Market, By End User
Hospitals
Clinics
Ambulatory Surgical Centers
Global Neuro-interventional Devices Market, By Region:
North America
By Product Type
Embolization Coils
Carotid Stents
Intracranial Stents
Neurovascular Thrombectomy
Flow Disruption
Flow Diverters
Intrasaccular Devices
Liquid Embolic Coils
Balloons
Stent Retrievers
By Technique
Neurothrombectomy Procedure
Cerebral Angiography
Stenting
Coiling Procedures
Flow Disruption
By End User
Hospitals
Clinics
Ambulatory Surgical Centers
By Country
U.S.
Canada
Latin America
By Product Type
Embolization Coils
Carotid Stents
Intracranial Stents
Neurovascular Thrombectomy
Flow Disruption
Flow Diverters
Intrasaccular Devices
Liquid Embolic Coils
Balloons
Stent Retrievers
By Technique
Neurothrombectomy Procedure
Cerebral Angiography
Stenting
Coiling Procedures
Flow Disruption
By End User
Hospitals
Clinics
Ambulatory Surgical Centers
By Country
Brazil
Mexico
Argentina
Rest of Latin America
Europe
By Product Type
Embolization Coils
Carotid Stents
Intracranial Stents
Neurovascular Thrombectomy
Flow Disruption
Flow Diverters
Intrasaccular Devices
Liquid Embolic Coils
Balloons
Stent Retrievers
By Technique
Neurothrombectomy Procedure
Cerebral Angiography
Stenting
Coiling Procedures
Flow Disruption
By End User
Hospitals
Clinics
Ambulatory Surgical Centers
By Country
Germany
U.K.
France
Italy
Spain
Russia
Rest of Europe
Asia Pacific
By Product Type
Embolization Coils
Carotid Stents
Intracranial Stents
Neurovascular Thrombectomy
Flow Disruption
Flow Diverters
Intrasaccular Devices
Liquid Embolic Coils
Balloons
Stent Retrievers
By Technique
Neurothrombectomy Procedure
Cerebral Angiography
Stenting
Coiling Procedures
Flow Disruption
By End User
Hospitals
Clinics
Ambulatory Surgical Centers
By Country
China
India
Japan
Australia
South Korea
ASEAN
Rest of Asia Pacific
Middle East
By Product Type
Embolization Coils
Carotid Stents
Intracranial Stents
Neurovascular Thrombectomy
Flow Disruption
Flow Diverters
Intrasaccular Devices
Liquid Embolic Coils
Balloons
Stent Retrievers
By Technique
Neurothrombectomy Procedure
Cerebral Angiography
Stenting
Coiling Procedures
Flow Disruption
By End User
Hospitals
Clinics
Ambulatory Surgical Centers
By Country
GCC
Israel
Rest of Middle East
Africa
By Product Type
Embolization Coils
Carotid Stents
Intracranial Stents
Neurovascular Thrombectomy
Flow Disruption
Flow Diverters
Intrasaccular Devices
Liquid Embolic Coils
Balloons
Stent Retrievers
By Technique
Neurothrombectomy Procedure
Cerebral Angiography
Stenting
Coiling Procedures
Flow Disruption
By End User
Hospitals
Clinics
Ambulatory Surgical Centers
By Country/Region
South Africa
Central Africa
North Africa
Company Profiles
Penumbra, Inc.*
Company Highlights
Products Portfolio
Key Highlights
Financial Performance
Strategies
Stryker Corporation
Medtronic PLC.
Johnson & Johnson Services, Inc.
Terumo Corporation
Insera Therapeutics Inc.
Anaconda Biomed S.L.
Perflow Medical Ltd.
“*” marked represents similar segmentation in other categories in the respective section.